In order to fully verify the organisational heterogeneity of CXCR4 between DVT patients and the control group, based on the results of differential analysis quantified by the external validation set, CXCR4 also demonstrated low expression as DEGs, exhibiting a significant trend between the two groups. This evidence concerns the gene CXCR4 and deep vein thrombosis.